| Stage | ENS | % of rev | ENR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $936M | 100.00% | $734M | 100.00% | ENS ×1.27 |
| Gross profit | $313M | 33.49% | $281M | 38.22% | ENR +4.7pp |
| Operating income | $151M | 16.18% | $90M | 12.22% | ENS +4.0pp |
| Pre-tax income | $135M | 14.43% | $50M | 6.78% | ENS +7.6pp |
| Net income | $116M | 12.45% | $40M | 5.44% | ENS +7.0pp |
| Stage | ENS | ENR | Gap · A − B |
|---|---|---|---|
| Revenue | $936M100.00% | $734M100.00% | ENS ×1.27 |
| Gross profit | 33.49%$313M | 38.22%$281M | ENR +4.7pp |
| Operating income | 16.18%$151M | 12.22%$90M | ENS +4.0pp |
| Pre-tax income | 14.43%$135M | 6.78%$50M | ENS +7.6pp |
| Net income |
| 12.45%$116M |
| 5.44%$40M |
| ENS +7.0pp |
No disclosed counterparties: ENR.
None